Contrasting effects of chronic, systemic treatment with mTOR inhibitors rapamycin and metformin on adult neural progenitors in mice

Yael Kusne, Emily L. Goldberg, Sara S. Parker, Sophie M. Hapak, Irina Y. Maskaykina, Wade M. Chew, Kirsten Limesand, Heddwen L Brooks, Theodore J. Price, Nader Sanai, Janko Nikolich-Zugich, Sourav Ghosh

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

The chronic and systemic administration of rapamycin extends life span in mammals. Rapamycin is a pharmacological inhibitor of mTOR. Metformin also inhibits mTOR signaling but by activating the upstream kinase AMPK. Here we report the effects of chronic and systemic administration of the two mTOR inhibitors, rapamycin and metformin, on adult neural stem cells of the subventricular region and the dendate gyrus of the mouse hippocampus. While rapamycin decreased the number of neural progenitors, metformin-mediated inhibition of mTOR had no such effect. Adult-born neurons are considered important for cognitive and behavioral health, and may contribute to improved health span. Our results demonstrate that distinct approaches of inhibiting mTOR signaling can have significantly different effects on organ function. These results underscore the importance of screening individual mTOR inhibitors on different organs and physiological processes for potential adverse effects that may compromise health span.

Original languageEnglish (US)
Pages (from-to)199-212
Number of pages14
JournalAge
Volume36
Issue number1
DOIs
StatePublished - 2014

Fingerprint

Metformin
Sirolimus
Health
Physiological Phenomena
Parahippocampal Gyrus
Adult Stem Cells
Neural Stem Cells
Mammals
Pharmacology
Neurons

Keywords

  • Metformin
  • MTOR
  • Neuronal progenitors
  • Rapamycin

ASJC Scopus subject areas

  • Aging
  • Geriatrics and Gerontology

Cite this

Kusne, Y., Goldberg, E. L., Parker, S. S., Hapak, S. M., Maskaykina, I. Y., Chew, W. M., ... Ghosh, S. (2014). Contrasting effects of chronic, systemic treatment with mTOR inhibitors rapamycin and metformin on adult neural progenitors in mice. Age, 36(1), 199-212. https://doi.org/10.1007/s11357-013-9572-5

Contrasting effects of chronic, systemic treatment with mTOR inhibitors rapamycin and metformin on adult neural progenitors in mice. / Kusne, Yael; Goldberg, Emily L.; Parker, Sara S.; Hapak, Sophie M.; Maskaykina, Irina Y.; Chew, Wade M.; Limesand, Kirsten; Brooks, Heddwen L; Price, Theodore J.; Sanai, Nader; Nikolich-Zugich, Janko; Ghosh, Sourav.

In: Age, Vol. 36, No. 1, 2014, p. 199-212.

Research output: Contribution to journalArticle

Kusne, Yael ; Goldberg, Emily L. ; Parker, Sara S. ; Hapak, Sophie M. ; Maskaykina, Irina Y. ; Chew, Wade M. ; Limesand, Kirsten ; Brooks, Heddwen L ; Price, Theodore J. ; Sanai, Nader ; Nikolich-Zugich, Janko ; Ghosh, Sourav. / Contrasting effects of chronic, systemic treatment with mTOR inhibitors rapamycin and metformin on adult neural progenitors in mice. In: Age. 2014 ; Vol. 36, No. 1. pp. 199-212.
@article{adeebaed1d5448528a85df6777779478,
title = "Contrasting effects of chronic, systemic treatment with mTOR inhibitors rapamycin and metformin on adult neural progenitors in mice",
abstract = "The chronic and systemic administration of rapamycin extends life span in mammals. Rapamycin is a pharmacological inhibitor of mTOR. Metformin also inhibits mTOR signaling but by activating the upstream kinase AMPK. Here we report the effects of chronic and systemic administration of the two mTOR inhibitors, rapamycin and metformin, on adult neural stem cells of the subventricular region and the dendate gyrus of the mouse hippocampus. While rapamycin decreased the number of neural progenitors, metformin-mediated inhibition of mTOR had no such effect. Adult-born neurons are considered important for cognitive and behavioral health, and may contribute to improved health span. Our results demonstrate that distinct approaches of inhibiting mTOR signaling can have significantly different effects on organ function. These results underscore the importance of screening individual mTOR inhibitors on different organs and physiological processes for potential adverse effects that may compromise health span.",
keywords = "Metformin, MTOR, Neuronal progenitors, Rapamycin",
author = "Yael Kusne and Goldberg, {Emily L.} and Parker, {Sara S.} and Hapak, {Sophie M.} and Maskaykina, {Irina Y.} and Chew, {Wade M.} and Kirsten Limesand and Brooks, {Heddwen L} and Price, {Theodore J.} and Nader Sanai and Janko Nikolich-Zugich and Sourav Ghosh",
year = "2014",
doi = "10.1007/s11357-013-9572-5",
language = "English (US)",
volume = "36",
pages = "199--212",
journal = "GeroScience",
issn = "2509-2715",
publisher = "Springer International Publishing AG",
number = "1",

}

TY - JOUR

T1 - Contrasting effects of chronic, systemic treatment with mTOR inhibitors rapamycin and metformin on adult neural progenitors in mice

AU - Kusne, Yael

AU - Goldberg, Emily L.

AU - Parker, Sara S.

AU - Hapak, Sophie M.

AU - Maskaykina, Irina Y.

AU - Chew, Wade M.

AU - Limesand, Kirsten

AU - Brooks, Heddwen L

AU - Price, Theodore J.

AU - Sanai, Nader

AU - Nikolich-Zugich, Janko

AU - Ghosh, Sourav

PY - 2014

Y1 - 2014

N2 - The chronic and systemic administration of rapamycin extends life span in mammals. Rapamycin is a pharmacological inhibitor of mTOR. Metformin also inhibits mTOR signaling but by activating the upstream kinase AMPK. Here we report the effects of chronic and systemic administration of the two mTOR inhibitors, rapamycin and metformin, on adult neural stem cells of the subventricular region and the dendate gyrus of the mouse hippocampus. While rapamycin decreased the number of neural progenitors, metformin-mediated inhibition of mTOR had no such effect. Adult-born neurons are considered important for cognitive and behavioral health, and may contribute to improved health span. Our results demonstrate that distinct approaches of inhibiting mTOR signaling can have significantly different effects on organ function. These results underscore the importance of screening individual mTOR inhibitors on different organs and physiological processes for potential adverse effects that may compromise health span.

AB - The chronic and systemic administration of rapamycin extends life span in mammals. Rapamycin is a pharmacological inhibitor of mTOR. Metformin also inhibits mTOR signaling but by activating the upstream kinase AMPK. Here we report the effects of chronic and systemic administration of the two mTOR inhibitors, rapamycin and metformin, on adult neural stem cells of the subventricular region and the dendate gyrus of the mouse hippocampus. While rapamycin decreased the number of neural progenitors, metformin-mediated inhibition of mTOR had no such effect. Adult-born neurons are considered important for cognitive and behavioral health, and may contribute to improved health span. Our results demonstrate that distinct approaches of inhibiting mTOR signaling can have significantly different effects on organ function. These results underscore the importance of screening individual mTOR inhibitors on different organs and physiological processes for potential adverse effects that may compromise health span.

KW - Metformin

KW - MTOR

KW - Neuronal progenitors

KW - Rapamycin

UR - http://www.scopus.com/inward/record.url?scp=84893095128&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84893095128&partnerID=8YFLogxK

U2 - 10.1007/s11357-013-9572-5

DO - 10.1007/s11357-013-9572-5

M3 - Article

C2 - 23949159

AN - SCOPUS:84893095128

VL - 36

SP - 199

EP - 212

JO - GeroScience

JF - GeroScience

SN - 2509-2715

IS - 1

ER -